 | • レポートコード：GIR-105X08095 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、血友病治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。血友病治療の種類別市場規模（血友病A、血友病B）、用途別市場規模（病院、製薬会社、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・血友病治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bayer、Novo Nordisk、Pfizer、Roche、Aptevo Therapeutics、Catalyst BioSciences、Dimension Therapeutics、Takeda、CSL Behring、Alnylam Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：血友病A、血友病B ・用途別分析2016年-2026年：病院、製薬会社、その他 ・血友病治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・血友病治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・血友病治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・血友病治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・血友病治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Haemophilia Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Haemophilia Treatment size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Haemophilia Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Haemophilia Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Haemophilia A
Haemophilia B
Market segment by Application can be divided into
Hospital
Pharmaceutical Companies
Other
The key market players for global Haemophilia Treatment market are listed below:
Bayer
Novo Nordisk
Pfizer
Roche
Aptevo Therapeutics
Catalyst BioSciences
Dimension Therapeutics
Takeda
CSL Behring
Alnylam Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Haemophilia Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Haemophilia Treatment Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Haemophilia A
1.2.3 Haemophilia B
1.3 Market Analysis by Application
1.3.1 Overview: Global Haemophilia Treatment Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmaceutical Companies
1.3.4 Other
1.4 Global Haemophilia Treatment Market Size & Forecast
1.4.1 Global Haemophilia Treatment Sales in Value (2016-2026))
1.4.2 Global Haemophilia Treatment Sales in Volume (2016-2026)
1.4.3 Global Haemophilia Treatment Price by Type (2016-2026) & (USD/Unit)
1.5 Global Haemophilia Treatment Production Capacity Analysis
1.5.1 Global Haemophilia Treatment Total Production Capacity (2016-2026)
1.5.2 Global Haemophilia Treatment Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Haemophilia Treatment Market Drivers
1.6.2 Haemophilia Treatment Market Restraints
1.6.3 Haemophilia Treatment Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Haemophilia Treatment Product and Services
2.1.4 Bayer Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Novo Nordisk
2.2.1 Novo Nordisk Details
2.2.2 Novo Nordisk Major Business
2.2.3 Novo Nordisk Haemophilia Treatment Product and Services
2.2.4 Novo Nordisk Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Haemophilia Treatment Product and Services
2.3.4 Pfizer Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Haemophilia Treatment Product and Services
2.4.4 Roche Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Aptevo Therapeutics
2.5.1 Aptevo Therapeutics Details
2.5.2 Aptevo Therapeutics Major Business
2.5.3 Aptevo Therapeutics Haemophilia Treatment Product and Services
2.5.4 Aptevo Therapeutics Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Catalyst BioSciences
2.6.1 Catalyst BioSciences Details
2.6.2 Catalyst BioSciences Major Business
2.6.3 Catalyst BioSciences Haemophilia Treatment Product and Services
2.6.4 Catalyst BioSciences Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Dimension Therapeutics
2.7.1 Dimension Therapeutics Details
2.7.2 Dimension Therapeutics Major Business
2.7.3 Dimension Therapeutics Haemophilia Treatment Product and Services
2.7.4 Dimension Therapeutics Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Takeda
2.8.1 Takeda Details
2.8.2 Takeda Major Business
2.8.3 Takeda Haemophilia Treatment Product and Services
2.8.4 Takeda Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 CSL Behring
2.9.1 CSL Behring Details
2.9.2 CSL Behring Major Business
2.9.3 CSL Behring Haemophilia Treatment Product and Services
2.9.4 CSL Behring Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Alnylam Pharmaceuticals
2.10.1 Alnylam Pharmaceuticals Details
2.10.2 Alnylam Pharmaceuticals Major Business
2.10.3 Alnylam Pharmaceuticals Haemophilia Treatment Product and Services
2.10.4 Alnylam Pharmaceuticals Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Haemophilia Treatment Sales by Manufacturer
3.1 Global Haemophilia Treatment Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Haemophilia Treatment Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Haemophilia Treatment
3.4 Market Concentration Rate
3.4.1 Top 3 Haemophilia Treatment Manufacturer Market Share
3.4.2 Top 6 Haemophilia Treatment Manufacturer Market Share
3.5 Global Haemophilia Treatment Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Haemophilia Treatment Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Haemophilia Treatment Market Size by Region
4.1.1 Global Haemophilia Treatment Sales in Volume by Region (2016-2026)
4.1.2 Global Haemophilia Treatment Revenue by Region (2016-2026)
4.2 North America Haemophilia Treatment Revenue (2016-2026)
4.3 Europe Haemophilia Treatment Revenue (2016-2026)
4.4 Asia-Pacific Haemophilia Treatment Revenue (2016-2026)
4.5 South America Haemophilia Treatment Revenue (2016-2026)
4.6 Middle East and Africa Haemophilia Treatment Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Haemophilia Treatment Sales in Volume by Type (2016-2026)
5.2 Global Haemophilia Treatment Revenue by Type (2016-2026)
5.3 Global Haemophilia Treatment Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Haemophilia Treatment Sales in Volume by Application (2016-2026)
6.2 Global Haemophilia Treatment Revenue by Application (2016-2026)
6.3 Global Haemophilia Treatment Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Haemophilia Treatment Sales by Type (2016-2026)
7.2 North America Haemophilia Treatment Sales by Application (2016-2026)
7.3 North America Haemophilia Treatment Market Size by Country
7.3.1 North America Haemophilia Treatment Sales in Volume by Country (2016-2026)
7.3.2 North America Haemophilia Treatment Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Haemophilia Treatment Sales by Type (2016-2026)
8.2 Europe Haemophilia Treatment Sales by Application (2016-2026)
8.3 Europe Haemophilia Treatment Market Size by Country
8.3.1 Europe Haemophilia Treatment Sales in Volume by Country (2016-2026)
8.3.2 Europe Haemophilia Treatment Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Haemophilia Treatment Sales by Type (2016-2026)
9.2 Asia-Pacific Haemophilia Treatment Sales by Application (2016-2026)
9.3 Asia-Pacific Haemophilia Treatment Market Size by Region
9.3.1 Asia-Pacific Haemophilia Treatment Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Haemophilia Treatment Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Haemophilia Treatment Sales by Type (2016-2026)
10.2 South America Haemophilia Treatment Sales by Application (2016-2026)
10.3 South America Haemophilia Treatment Market Size by Country
10.3.1 South America Haemophilia Treatment Sales in Volume by Country (2016-2026)
10.3.2 South America Haemophilia Treatment Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Haemophilia Treatment Sales by Type (2016-2026)
11.2 Middle East & Africa Haemophilia Treatment Sales by Application (2016-2026)
11.3 Middle East & Africa Haemophilia Treatment Market Size by Country
11.3.1 Middle East & Africa Haemophilia Treatment Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Haemophilia Treatment Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Haemophilia Treatment Typical Distributors
12.3 Haemophilia Treatment Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Haemophilia Treatment Revenue by Type, (USD Million), 2021-2026
Table 2. Global Haemophilia Treatment Revenue by Application, (USD Million), 2021-2026
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Haemophilia Treatment Product and Services
Table 6. Bayer Haemophilia Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 8. Novo Nordisk Major Business
Table 9. Novo Nordisk Haemophilia Treatment Product and Services
Table 10. Novo Nordisk Haemophilia Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Haemophilia Treatment Product and Services
Table 14. Pfizer Haemophilia Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Roche Basic Information, Manufacturing Base and Competitors
Table 16. Roche Major Business
Table 17. Roche Haemophilia Treatment Product and Services
Table 18. Roche Haemophilia Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Aptevo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 20. Aptevo Therapeutics Major Business
Table 21. Aptevo Therapeutics Haemophilia Treatment Product and Services
Table 22. Aptevo Therapeutics Haemophilia Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Catalyst BioSciences Basic Information, Manufacturing Base and Competitors
Table 24. Catalyst BioSciences Major Business
Table 25. Catalyst BioSciences Haemophilia Treatment Product and Services
Table 26. Catalyst BioSciences Haemophilia Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Dimension Therapeutics Basic Information, Manufacturing Base and Competitors
Table 28. Dimension Therapeutics Major Business
Table 29. Dimension Therapeutics Haemophilia Treatment Product and Services
Table 30. Dimension Therapeutics Haemophilia Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Takeda Basic Information, Manufacturing Base and Competitors
Table 32. Takeda Major Business
Table 33. Takeda Haemophilia Treatment Product and Services
Table 34. Takeda Haemophilia Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 36. CSL Behring Major Business
Table 37. CSL Behring Haemophilia Treatment Product and Services
Table 38. CSL Behring Haemophilia Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Alnylam Pharmaceuticals Major Business
Table 41. Alnylam Pharmaceuticals Haemophilia Treatment Product and Services
Table 42. Alnylam Pharmaceuticals Haemophilia Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Haemophilia Treatment Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Haemophilia Treatment Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Haemophilia Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Haemophilia Treatment Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Haemophilia Treatment Production Site of Key Manufacturer
Table 48. Global Haemophilia Treatment Sales by Region (2016-2021e) & (K Units)
Table 49. Global Haemophilia Treatment Sales by Region (2021-2026) & (K Units)
Table 50. Global Haemophilia Treatment Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Haemophilia Treatment Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Haemophilia Treatment Sales by Type (2016-2021e) & (K Units)
Table 53. Global Haemophilia Treatment Sales by Type (2021-2026) & (K Units)
Table 54. Global Haemophilia Treatment Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Haemophilia Treatment Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Haemophilia Treatment Price by Type (2016-2021e) & (USD/Unit)
Table 57. Global Haemophilia Treatment Price by Type (2021-2026) & (USD/Unit)
Table 58. Global Haemophilia Treatment Sales by Application (2016-2021e) & (K Units)
Table 59. Global Haemophilia Treatment Sales by Application (2021-2026) & (K Units)
Table 60. Global Haemophilia Treatment Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Haemophilia Treatment Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Haemophilia Treatment Price by Application (2016-2021e) & (USD/Unit)
Table 63. Global Haemophilia Treatment Price by Application (2021-2026) & (USD/Unit)
Table 64. North America Haemophilia Treatment Sales by Country (2016-2021e) & (K Units)
Table 65. North America Haemophilia Treatment Sales by Country (2021-2026) & (K Units)
Table 66. North America Haemophilia Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Haemophilia Treatment Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Haemophilia Treatment Sales by Type (2016-2021e) & (K Units)
Table 69. North America Haemophilia Treatment Sales by Type (2021-2026) & (K Units)
Table 70. North America Haemophilia Treatment Sales by Application (2016-2021e) & (K Units)
Table 71. North America Haemophilia Treatment Sales by Application (2021-2026) & (K Units)
Table 72. Europe Haemophilia Treatment Sales by Country (2016-2021e) & (K Units)
Table 73. Europe Haemophilia Treatment Sales by Country (2021-2026) & (K Units)
Table 74. Europe Haemophilia Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Haemophilia Treatment Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Haemophilia Treatment Sales by Type (2016-2021e) & (K Units)
Table 77. Europe Haemophilia Treatment Sales by Type (2021-2026) & (K Units)
Table 78. Europe Haemophilia Treatment Sales by Application (2016-2021e) & (K Units)
Table 79. Europe Haemophilia Treatment Sales by Application (2021-2026) & (K Units)
Table 80. Asia-Pacific Haemophilia Treatment Sales by Region (2016-2021e) & (K Units)
Table 81. Asia-Pacific Haemophilia Treatment Sales by Region (2021-2026) & (K Units)
Table 82. Asia-Pacific Haemophilia Treatment Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Haemophilia Treatment Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Haemophilia Treatment Sales by Type (2016-2021e) & (K Units)
Table 85. Asia-Pacific Haemophilia Treatment Sales by Type (2021-2026) & (K Units)
Table 86. Asia-Pacific Haemophilia Treatment Sales by Application (2016-2021e) & (K Units)
Table 87. Asia-Pacific Haemophilia Treatment Sales by Application (2021-2026) & (K Units)
Table 88. South America Haemophilia Treatment Sales by Country (2016-2021e) & (K Units)
Table 89. South America Haemophilia Treatment Sales by Country (2021-2026) & (K Units)
Table 90. South America Haemophilia Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Haemophilia Treatment Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Haemophilia Treatment Sales by Type (2016-2021e) & (K Units)
Table 93. South America Haemophilia Treatment Sales by Type (2021-2026) & (K Units)
Table 94. South America Haemophilia Treatment Sales by Application (2016-2021e) & (K Units)
Table 95. South America Haemophilia Treatment Sales by Application (2021-2026) & (K Units)
Table 96. Middle East & Africa Haemophilia Treatment Sales by Country (2016-2021e) & (K Units)
Table 97. Middle East & Africa Haemophilia Treatment Sales by Country (2021-2026) & (K Units)
Table 98. Middle East & Africa Haemophilia Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Haemophilia Treatment Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Haemophilia Treatment Sales by Type (2016-2021e) & (K Units)
Table 101. Middle East & Africa Haemophilia Treatment Sales by Type (2021-2026) & (K Units)
Table 102. Middle East & Africa Haemophilia Treatment Sales by Application (2016-2021e) & (K Units)
Table 103. Middle East & Africa Haemophilia Treatment Sales by Application (2021-2026) & (K Units)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Haemophilia Treatment Typical Distributors
Table 107. Haemophilia Treatment Typical Customers
List of Figures
Figure 1. Haemophilia Treatment Picture
Figure 2. Global Haemophilia Treatment Sales Market Share by Type in 2020
Figure 3. Haemophilia A
Figure 4. Haemophilia B
Figure 5. Global Haemophilia Treatment Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Pharmaceutical Companies
Figure 8. Other
Figure 9. Global Haemophilia Treatment Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Haemophilia Treatment Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Haemophilia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Haemophilia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Haemophilia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Haemophilia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Haemophilia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Haemophilia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Haemophilia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Haemophilia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Haemophilia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Haemophilia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Haemophilia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Haemophilia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Haemophilia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Haemophilia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Haemophilia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Haemophilia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Haemophilia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Haemophilia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Haemophilia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Haemophilia Treatment Sales (2016-2026) & (K Units)
Figure 31. Global Haemophilia Treatment Production Capacity (2016-2026) & (K Units)
Figure 32. Global Haemophilia Treatment Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Haemophilia Treatment Market Drivers
Figure 34. Haemophilia Treatment Market Restraints
Figure 35. Haemophilia Treatment Market Trends
Figure 36. Global Haemophilia Treatment Sales Market Share by Manufacturer in 2020
Figure 37. Global Haemophilia Treatment Revenue Market Share by Manufacturer in 2020
Figure 38. Haemophilia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Haemophilia Treatment Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Haemophilia Treatment Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Haemophilia Treatment Sales Market Share by Region (2016-2026)
Figure 42. Global Haemophilia Treatment Revenue Market Share by Region (2016-2026)
Figure 43. North America Haemophilia Treatment Revenue (2016-2026) & (USD Million)
Figure 44. Europe Haemophilia Treatment Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Haemophilia Treatment Revenue (2016-2026) & (USD Million)
Figure 46. South America Haemophilia Treatment Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Haemophilia Treatment Revenue (2016-2026) & (USD Million)
Figure 48. Global Haemophilia Treatment Sales Market Share by Type (2016-2026)
Figure 49. Global Haemophilia Treatment Revenue Market Share by Type (2016-2026)
Figure 50. Global Haemophilia Treatment Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Haemophilia Treatment Sales Market Share by Application (2016-2026)
Figure 52. Global Haemophilia Treatment Revenue Market Share by Application (2016-2026)
Figure 53. Global Haemophilia Treatment Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Haemophilia Treatment Sales Market Share by Country (2016-2026)
Figure 55. North America Haemophilia Treatment Revenue Market Share by Country (2016-2026)
Figure 56. North America Haemophilia Treatment Sales Market Share by Type (2016-2026)
Figure 57. North America Haemophilia Treatment Sales Market Share by Application (2016-2026)
Figure 58. Europe Haemophilia Treatment Sales Market Share by Country (2016-2026)
Figure 59. Europe Haemophilia Treatment Revenue Market Share by Country (2016-2026)
Figure 60. Europe Haemophilia Treatment Sales Market Share by Type (2016-2026)
Figure 61. Europe Haemophilia Treatment Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Haemophilia Treatment Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Haemophilia Treatment Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Haemophilia Treatment Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Haemophilia Treatment Sales Market Share by Application (2016-2026)
Figure 66. South America Haemophilia Treatment Sales Market Share by Country (2016-2026)
Figure 67. South America Haemophilia Treatment Revenue Market Share by Country (2016-2026)
Figure 68. South America Haemophilia Treatment Sales Market Share by Type (2016-2026)
Figure 69. South America Haemophilia Treatment Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Haemophilia Treatment Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Haemophilia Treatment Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Haemophilia Treatment Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Haemophilia Treatment Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
好中球減少症治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Neutropenia is an abnormal condition, characterized by critically low levels of circulating neutrophils, a type of WBC found in the blood. These cells make up for the majority of circulating lymphocytes and help defend the body against infections by bacteria, viruses, and other pathogenic organisms.…- 世界のドライアイ治療用装置市場 2021：企業別、地域別、種類・用途別 The Dry Eye Treatment Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界のIBD（潰瘍性大腸炎＆クローン病）治療市場 2021：企業別、地域別、種類・用途別 The IBD (Ulcerative Colitis and Crohn's Disease) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value ch…
- 変形性関節症の治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Osteoarthritis (OA) is a type of joint disease that results from breakdown of joint cartilage and underlying bone. The most common symptoms are joint pain and stiffness. Initially, symptoms may occur only following exercise, but over time may become constant. Other symptoms may include joint swellin…
- 単純ヘルペスウイルス治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 The genital herpes treatment includes the use of drug types like Acyclovir that can treat herpes virus infections, including shingles. This medication does not cure herpes, but may prevent herpes sores or blisters. It is also used to treat outbreaks of genital herpes. In people with frequent outbrea…